Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Immuno-Capture Technology Optimized for Mass Spectrometer Detection

By HospiMedica staff writers
Posted on 10 Apr 2007
A next-generation immuno-capture technology has been optimized for mass spectrometer (MS) detection. More...
Immuno-catch is a powerful alternative to slower, low-yield immunoprecipitation assays. The novel technology offers a promise of molecular diagnostics for the detection using standard MS and gel technologies and new capabilities for advanced peptide and protein research.

The new kit consists of streptavidin-coated 96 well microplates and all the necessary buffers for binding and elution from the plate. The streptavidin coating procedure provides a high binding capacity for biotinylated capture agents, including antibodies, but also an extremely robust coating to allow easy elution of captured analytes. These qualities provide a high-throughput, multiplex format for the enrichment of specific target proteins and peptides from complex biological samples (such as blood serum).

PerkinElmer Life and Analytical Sciences (Waltham, MA, USA) developed the new kit, which is called the Immuno-catch kit. In addition to conventional immunoassays of intact proteins, the kit was designed to meet the unique requirements of investigators interested in the low-molecular weight peptidomic environment. Researchers in the emerging discipline of peptidomics are very interested in peptide fragments as important markers of cellular signals and as potential markers of diagnostic information.

PerkinElmer is currently collaborating with Drs. Lance Liotta and Emanuel Petricoin, co-directors of the Center for Applied Proteomics and Molecular Medicine at George Mason University (Fairfax County, VA, USA) for the investigation of possible clinical utility of peptidomics and Immuno-catch. According to Dr Liotta, "The Immuno-catch platform provides a critical component for our ongoing alliance with PerkinElmer to explore the peptidome, which we hypothesize to hold untapped and significant diagnostic potential.

In addition to conventional immunoassays of intact proteins, the Immuno-catch kit was designed to meet the unique requirements of investigators interested in the low-molecular weight peptidomic environment. Researchers in the emerging discipline of peptidomics have great interest in peptide fragments as important markers of cellular signals and as potential markers of diagnostic information.


Related Links:
PerkinElmer

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
PACS Workstation
PaxeraView PRO
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.